drugset / Trial / NCT01954966

Progesterone and Brain Imaging Study

NCT01954966

RandomizedCrossoverDouble-blindTreatment

Summary

Male and female smokers were recruited to undergo 2 phases of smoking cessation. Each phase was 4 days long and involved 3 brain-imaging scans, blood draws and an intervention involving progesterone or a matched placebo.

Timeline

Start
2010-11
Primary completion
2021-12
Completion
2021-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Oral

Indications